Cargando…

Efficacy of high-dose intravenous immunoglobulin in severe and critical COVID-19: A retrospective cohort study

BACKGROUND: Various immunomodulatory therapies have been explored to manage the dysregulated immune response seen in severe COVID-19 infection. The objective of this study was to evaluate the efficacy of intravenous immunoglobulin (IVIG) in severe and critical COVID-19 disease. METHODS: This retrosp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aggarwal, Ritesh, Dewan, Arun, Pandey, Ankita, Trehan, Nikita, Majid, Muhammad Aamir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825318/ https://www.ncbi.nlm.nih.gov/pubmed/35168081 http://dx.doi.org/10.1016/j.intimp.2022.108615

Ejemplares similares

Comparison of nephrotoxicity of Colistin with Polymyxin B administered in currently recommended doses: a prospective study
por: Aggarwal, Ritesh, et al.
Publicado: (2018)

Efficacy of single-dose intravenous immunoglobulin administration for severe sepsis and septic shock
por: Hamano, Nobuyuki, et al.
Publicado: (2013)

High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China
por: Cao, Wei, et al.
Publicado: (2021)

Intravenous immunoglobulins (IVIG) in severe/critical COVID-19 adult patients
por: Kwapisz, Dorota, et al.
Publicado: (2023)

Intravenous immunoglobulin therapy could have efficacy in severe sepsis
por: Kim, Ahmin, et al.
Publicado: (2013)

Corrigendum: High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China
por: Cao, Wei, et al.
Publicado: (2021)

Intravenous immunoglobulin efficacy on pembrolizumab induced severe toxic epidermal necrolysis
por: Kian, Waleed, et al.
Publicado: (2021)

Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID‐19: a multicenter retrospective cohort study
por: Shao, Ziyun, et al.
Publicado: (2020)

The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?
por: Han, Ji Whan
Publicado: (2017)

What's new in critical illness and injury science? Intravenous immunoglobulin for COVID-19 with severe or critical illness
por: Miller, Andrew C., et al.
Publicado: (2020)

Long-term efficacy of high doses of intravenous immunoglobulins in generalized scleromyxoedema: Case report
por: Arginelli, Federica, et al.
Publicado: (2016)

Efficacy of High-Dose Polyclonal Intravenous Immunoglobulin in COVID-19: A Systematic Review
por: Focosi, Daniele, et al.
Publicado: (2022)

Intravenous Immunoglobulin for Severe Protracted Pediatric Guillain–Barre Syndrome: Is Single Dose Adequate?
por: Madaan, Priyanka, et al.
Publicado: (2019)

High-Dose Intravenous Immunoglobulin in Skin Autoimmune Disease
por: Hoffmann, Jochen H. O., et al.
Publicado: (2019)

The safety and efficacy of intravenous immunoglobulin in autoimmune encephalitis
por: Lee, Soon‐Tae, et al.
Publicado: (2022)

Intravenous Immunoglobulin-Associated Severe Hemolytic Anemia
por: KC, Ojbindra, et al.
Publicado: (2023)

Intravenous immunoglobulin treatment for patients with severe COVID-19: a retrospective multicentre study
por: Liu, Jiao, et al.
Publicado: (2021)

Long-term Efficacy of Intravenous Immunoglobulin Therapy for Moderate to Severe Childhood Atopic Dermatitis
por: Jee, Sue-Jung, et al.
Publicado: (2011)

Efficacy of Glucocorticoid plus Intravenous Immunoglobulin in Children with Immunoglobulin-Insensitive Kawasaki Disease
por: Ma, Yongmei, et al.
Publicado: (2022)

PRACTICAL ISSUES FOR CLINICIANS USING HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN
por: Khan, S, et al.
Publicado: (2011)

High dose intravenous immunoglobulin may be complicated by myocardial infarction
por: Vinod, Kolar Vishwanath, et al.
Publicado: (2014)

High-dose intravenous immunoglobulin therapy for eosinophilic granulomatosis with polyangiitis
por: Tsurikisawa, Naomi, et al.
Publicado: (2014)

Adjuvant intravenous immunoglobulin administration on postoperative critically ill patients with secondary peritonitis: a retrospective study
por: Choi, Young Un, et al.
Publicado: (2023)

Intravenous Immunoglobulin in the Treatment of Severe Clostridium Difficile Colitis
por: Shah, Nihar, et al.
Publicado: (2014)

High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects
por: Liu, Xiaosheng, et al.
Publicado: (2020)

Retracted: Efficacy of Glucocorticoid plus Intravenous Immunoglobulin in Children with Immunoglobulin-Insensitive Kawasaki Disease
por: Healthcare Engineering, Journal of
Publicado: (2023)

Efficacy evaluation of intravenous immunoglobulin in non-severe patients with COVID-19: A retrospective cohort study based on propensity score matching
por: Huang, Chenlu, et al.
Publicado: (2021)

Erratum to "Adjuvant intravenous immunoglobulin administration on postoperative critically ill patients with secondary peritonitis: a retrospective study"
por: Choi, Young Un, et al.
Publicado: (2023)

INTRAVENOUS IMMUNOGLOBULIN IN DERMATOLOGY
por: Dhar, Sandipan
Publicado: (2009)

Low-dose Methotrexate Therapy for Intravenous Immunoglobulin-resistant Kawasaki Disease
por: Lee, Taek Jin, et al.
Publicado: (2008)

High-dose of intravenous immunoglobulin modulates immune tolerance in premature infants
por: Liu, Pin, et al.
Publicado: (2018)

Intravenous Immunoglobulin Protects Against Severe Pandemic Influenza Infection
por: Rockman, Steven, et al.
Publicado: (2017)

Successful intravenous immunoglobulin treatment in severe COVID-19 pneumonia
por: Lanza, Maurizia, et al.
Publicado: (2020)

Salvage therapy with high dose Intravenous Immunoglobulins in acquired Von Willebrand Syndrome and unresponsive severe intestinal bleeding
por: Cugno, Massimo, et al.
Publicado: (2014)

High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats
por: Meregalli, Cristina, et al.
Publicado: (2018)

Severe Coronavirus Disease 2019 That Recovered from Respiratory Failure by Treatment That Included High-dose Intravenous Immunoglobulin
por: Suzuki, Yasuhito, et al.
Publicado: (2020)

Clinical Efficacy of Intravenous Immunoglobulins in Management of Toxic Shock Syndrome: An Updated Literature Review
por: Amreen, Sana, et al.
Publicado: (2021)

Intravenous Immunoglobulin Therapy for Critically Ill COVID-19 Patients With Different Inflammatory Phenotypes: A Multicenter, Retrospective Study
por: Chen, Yan, et al.
Publicado: (2022)

The importance of intravenous immunoglobulin treatment in critically ill patients with necrotizing soft tissue infection: a retrospective cohort study
por: Hofmaenner, Daniel A., et al.
Publicado: (2022)

Intravenous immunoglobulin-based adjuvant therapy for severe COVID-19: a single-center retrospective cohort study
por: Hou, Xiao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u5h6c4233br865fthsf4huvvne